Truncating RNF43 mutations may alter WNT signaling, but these are predominantly present in mismatch repair deficient BRAF mutant cancer [2,8], and there is controversy as to whether RNF43 mutation affects canonical WNT signaling [9]. The gene discussed is BRAF; the disease is cancer.